Ashwagandha is often marketed as if it works like an immediate sedative: take a capsule, feel sleepy, fall asleep. Human research does not support such a simple story. The better-supported interpretation is that some specific ashwagandha extracts have produced modest improvements in sleep quality and several sleep measures when taken consistently for weeks.

For Biogénique Ashwagandha, there is also an important regulatory distinction. The current product label is licensed for traditional Ayurvedic use as a sleep aid. That licensed traditional claim is not the same as saying that every modern clinical trial on KSM-66, Shoden or another proprietary extract proves a clinical sleep effect for Biogénique’s 10:1 root extract.

1. What do the systematic reviews say about ashwagandha and sleep?

A sleep-focused systematic review and meta-analysis published in PLOS One in 2021 pooled five randomized controlled trials involving 400 adults. Across the studies, ashwagandha extract produced a small but statistically significant improvement in overall sleep compared with placebo (standardized mean difference -0.59; 95% CI -0.75 to -0.42), with moderate heterogeneity (I² = 62%).

That 2021 review reported more pronounced effects in participants with insomnia, in trials using at least 600 mg/day, and in trials lasting at least eight weeks. Those subgroup findings are useful for understanding the literature, but they are not a dosing instruction for Biogénique: the included studies used different extracts and standardization methods.

A newer 2024 systematic review and meta-analysis searched randomized trials through August 2023. It pooled five RCTs (254 participants) in anxiety and/or insomnia populations and reported significant improvements in sleep onset latency, total sleep time, PSQI and sleep efficiency, but not wake after sleep onset or total time in bed. Its authors also concluded that larger studies are needed to confirm the findings.

The evidence base is therefore directionally positive but still small. The 2021 sleep review included only five trials, all conducted in India, and one trial disclosed partial manufacturer sponsorship. NIH’s Office of Dietary Supplements likewise notes that different preparations and doses make it difficult to recommend a specific extract or amount.

Source: Cheah et al. 2021 - PLOS One | Fatima et al. 2024 - PubMed | NIH ODS - Health Professional Fact Sheet

2. What did the main randomized sleep trials actually find?

The trials below show why “ashwagandha works for sleep” needs context. They used different populations, extracts and doses. Results from a named proprietary extract cannot automatically be treated as evidence for a different finished product.

Source: Langade 2019 - PMC | Deshpande 2020 - PubMed | Langade 2021 - PubMed | Movva 2026 - PubMed

3. Does ashwagandha make you sleepy right away?

Not necessarily. Current Health Canada ingredient guidance acknowledges that drowsiness may occur and advises caution when driving or operating machinery. NCCIH also lists drowsiness among possible side effects. But the sleep trials generally evaluated changes after six to ten weeks of regular use, not minutes after a single capsule.

That distinction matters. “May cause drowsiness” is a safety observation; it is not proof that ashwagandha functions as a fast-acting hypnotic. If you feel drowsy after taking any product, avoid driving or hazardous tasks and discuss persistent or concerning effects with a healthcare professional.

Source: Health Canada Ashwagandha monograph | NCCIH Ashwagandha safety overview

4. Is the evidence stronger for insomnia than for generally poor sleep?

Probably, but the evidence is still limited. The 2021 meta-analysis found the pooled sleep effect was more pronounced among participants diagnosed with insomnia. A randomized study that enrolled both healthy adults and adults with insomnia likewise reported larger improvements in the insomnia group.

That does not mean ashwagandha should be presented as a treatment for chronic insomnia. Insomnia can have medical, psychiatric, medication-related or behavioural causes, and persistent sleep problems deserve proper evaluation. Biogénique’s licensed claim is a traditional Ayurvedic sleep-aid claim—not a disease-treatment claim.

5. How long did the sleep studies take to show results?

Most of the better-known randomized sleep trials assessed outcomes over several weeks: six weeks in the Shoden non-restorative-sleep study, eight weeks in the healthy/insomnia study, eight weeks in the 2026 KSM-66 comparison trial, and ten weeks in the 2019 insomnia trial.

That makes one practical point clear: the clinical evidence does not support promising an immediate effect after the first dose. It also does not justify guaranteeing a specific “works in 7 days” timeline for Biogénique. Different extracts, doses, populations and endpoints make a single onset claim unreliable.

6. Why extract identity matters more than the milligram number alone

Two products can both say “ashwagandha” and still be materially different. Relevant variables include plant part, extraction ratio, solvent, standardization to withanolides or withanolide glycosides, and the amount of dried plant represented by the extract.

Biogénique’s current label identifies a root extract at 500 mg per capsule, 10:1, with a QCE of 5,000 mg dried root. It does not identify the extract as KSM-66 or Shoden and does not state the same withanolide standardization used in those proprietary-extract trials. Therefore, comparing 500 mg of Biogénique with 300 mg or 120 mg in another study without accounting for extract identity is misleading.

7. What Biogénique Ashwagandha is actually licensed to say

Source: Current Biogénique Product Facts label, NPN 80067337 (internal Drive, verified August 17, 2026) | Biogénique Ashwagandha - current product page

The licensed sleep-aid wording is the product-specific claim. External trials can explain the broader scientific evidence, but they should not be rewritten as if Health Canada licensed Biogénique to claim improved actigraphy, shortened sleep latency or treatment of insomnia.

8. Current Health Canada ingredient guidance: useful, but not identical to the product label

Health Canada’s current Ashwagandha monograph, dated February 28, 2025, includes traditional Ayurvedic use to help relieve restlessness and/or nervousness, which helps promote sleep. It also includes broader ingredient-level warnings: consult a healthcare professional before use if pregnant or breastfeeding, and exercise caution when driving or using machinery because drowsiness may occur.

Those monograph statements are current ingredient-level guidance. The existing Biogénique finished-product label remains the highest-priority source for the exact licensed directions and warnings printed for this specific product.

Source: Health Canada monograph - February 28, 2025

9. Safety matters more when sleep is the goal

Sleep products are often combined casually. That is exactly where the Biogénique label deserves attention: it states that consumption with alcohol, other drugs or natural health products with sedative properties is not recommended. Do not assume that adding melatonin, an antihistamine, a prescription sedative or alcohol is automatically appropriate simply because one study tested a specific combination.

Broader NCCIH guidance also flags possible drowsiness, gastrointestinal effects, rare reports of liver injury, potential thyroid effects and medication interactions. It advises against ashwagandha during pregnancy and breastfeeding and notes concerns for people with thyroid or autoimmune disorders or those preparing for surgery. These are broader evidence-based safety considerations, not all statements printed on the current Biogénique label.

Source: NCCIH - Usefulness and Safety | NIH ODS - Consumer Fact Sheet

10. Quality First: what lot 240525 testing actually shows

Clinical evidence only matters if the finished product itself meets its specifications. Biogénique’s Certificate of Analysis for lot 240525 provides batch-specific physical, microbial, pathogen and heavy-metal testing.

The tested lot met the listed specifications. Under Biogénique’s 3X PUR™ interpretation framework, these results can be organized as Purity (microbial, pathogen and heavy-metal testing), Quality (capsule specifications) and Performance (disintegration). 3X PUR™ is Biogénique’s framework for interpreting lot testing; it is not a laboratory-issued certification.

The 11-minute disintegration result must not be described as “11-minute absorption.” Disintegration measures how quickly the capsule breaks apart under the test conditions; it does not measure blood levels, bioavailability, sleep onset or clinical effectiveness.

Source: Biogénique Quality Control / COA search

A practical decision framework: is ashwagandha a reasonable sleep supplement to consider?

Frequently Asked Questions

Does ashwagandha help you sleep?

Some randomized trials and systematic reviews suggest that certain ashwagandha extracts can improve several sleep outcomes, including sleep latency, sleep efficiency and total sleep time. The evidence is promising but still limited, and study preparations are heterogeneous.

Does ashwagandha make you sleepy?

It can cause drowsiness in some people, according to current Health Canada ingredient guidance and NCCIH. That is not the same as proving an immediate sedative effect in everyone.

Is Biogénique Ashwagandha licensed for sleep?

Yes. The current finished-product label says it is traditionally used in Ayurveda as a sleep aid. That is a traditional-use claim, not a claim that Biogénique has been clinically proven to treat insomnia.

How long does ashwagandha take to work for sleep?

There is no single proven onset time. Major randomized sleep studies assessed outcomes after about 6 to 10 weeks. Those timelines cannot be guaranteed for Biogénique because the studied extracts were different.

Is 500 mg enough for sleep?

The number alone cannot answer that. Biogénique contains 500 mg of a 10:1 root extract with QCE 5,000 mg and is labeled for one capsule daily. Research studies used different standardized extracts, so 500 mg is not directly comparable with 120 mg, 300 mg or 600 mg in another product.

Should I take ashwagandha at night?

That timing question is covered separately in Blog 6. The current Biogénique label says one capsule once daily and does not specify a clock time.

Can I combine ashwagandha with melatonin?

Do not assume the 2026 combination study means the combination is appropriate for everyone. The current Biogénique label advises against use with other drugs or natural health products with sedative properties. Ask a healthcare professional before combining sedating products.

Can ashwagandha replace treatment for insomnia?

No. Evidence from some extracts is promising, but Biogénique is not licensed to treat insomnia, and persistent sleep problems should be assessed appropriately.

Bottom Line

Ashwagandha has a more credible sleep evidence base than the extremes on the internet suggest. It is neither “proven to cure insomnia” nor “just placebo.” A 2021 sleep-focused meta-analysis found a small overall benefit; a 2024 systematic review/meta-analysis also reported improvements in several sleep outcomes; and a newer 2026 randomized trial adds further evidence. The body of evidence is still relatively small and heterogeneous.

The limitation is just as important as the positive signal: studies used different proprietary extracts, doses and populations. Their results cannot be automatically transferred to Biogénique’s 500 mg 10:1 root extract.

For Biogénique, the strongest product-specific statement is the one Health Canada actually licensed on the finished-product label: it is traditionally used in Ayurveda as a sleep aid. The product provides 500 mg of 10:1 root extract (QCE 5,000 mg), adults take one capsule once daily, and lot 240525 met its listed finished-product specifications.

Related Biogénique Resources

• Biogénique Ashwagandha 500 mg - Product Details

• Quality Control / Certificates of Analysis

• VitaQuiz / Find My Formula

• Sleep Better Feel Better: Starting Now!

Evidence & Compliance Note

Biogénique licensed claims in this article come from the current finished-product label for NPN 80067337. Health Canada monograph statements are identified as ingredient-level guidance. NIH/NCCIH information and randomized trials are external scientific evidence. Clinical outcomes from KSM-66, Shoden and other proprietary preparations are not presented as authorized Biogénique product claims and are not assumed to prove the same magnitude, timing or clinical effect for Biogénique’s 10:1 root extract.

References

1. Biogénique Ashwagandha current Product Facts label. NPN 80067337. Lot 240525. Internal product file verified August 17, 2026.

2. Health Canada. Natural Health Product Monograph: Ashwagandha - Withania somnifera. February 28, 2025. Source

3. NIH Office of Dietary Supplements. Ashwagandha: Is it helpful for stress, anxiety, or sleep? Health Professional Fact Sheet. Source

4. National Center for Complementary and Integrative Health. Ashwagandha: Usefulness and Safety. Source

5. Cheah KL, Norhayati MN, Yaacob LH, Abdul Rahman R. Effect of Ashwagandha (Withania somnifera) extract on sleep: a systematic review and meta-analysis. PLoS One. 2021;16(9):e0257843. Source

6. Fatima K, Malik J, Muskan F, et al. Safety and efficacy of Withania somnifera for anxiety and insomnia: Systematic review and meta-analysis. Hum Psychopharmacol. 2024;39(6):e2911. Source

7. Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D. Efficacy and Safety of Ashwagandha Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study. Cureus. 2019;11(9):e5797. Source

8. Deshpande A, et al. A randomized, double blind, placebo controlled study to evaluate the effects of ashwagandha extract on sleep quality in healthy adults. Sleep Med. 2020;72:28-36. Source

9. Langade D, Thakare V, Kanchi S, Kelgane S. Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients. J Ethnopharmacol. 2021;264:113276. Source

10. Movva N, Salve J, Wankhede K, Thakare V, Langade D. Comparative Evaluation of Ashwagandha Root Extract and Melatonin for Improving Sleep Quality in Adults. Clocks & Sleep. 2026;8(2):15. Source

11. Biogénique Ashwagandha Certificate of Analysis. Lot 240525. Manufactured May 2024; expiry April 2027; quality approval October 25, 2024. Internal COA verified August 17, 2026.

Disclaimer